Multiple-variable dose regimen for treating TNFalpha-related disorders

Details for Australian Patent Application No. 2011218744 (hide)

Owner Abbott Biotechnology Ltd.

Inventors Chartash, Elliot; Granneman, George Richard; Hoffman, Rebeca S.; Yan, Philip; Taylor, Lori K.

Agent Spruson & Ferguson

Pub. Number AU-B-2011218744

Parent 2005244261

Filing date 2 September 2011

Wipo publication date 22 September 2011

Acceptance publication date 20 September 2012

International Classifications

C07K 16/24 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/00 Medicinal preparations containing peptides

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 39/40 Medicinal preparations containing antigens or antibodies - bacterial

A61P 17/06 Drugs for dermatological disorders

A61P 37/00 Drugs for immunological or allergic disorders

Event Publications

15 September 2011 Complete Application Filed

22 September 2011 Application Open to Public Inspection

  Published as AU-B-2011218744

20 September 2012 Application Accepted

  Published as AU-B-2011218744

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011218745-Pump and nozzle liquid flow control system

2011218743-Methods of administering anti-TNFalpha antibodies